Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2017

02.08.2016 | Original Research

Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study

verfasst von: Richard A. Deyo, MD, MPH, Sara E. Hallvik, MPH, Christi Hildebran, LMSW, Miguel Marino, PhD, Eve Dexter, MS, Jessica M. Irvine, MS, Nicole O’Kane, PharmD, Joshua Van Otterloo, MSPH, Dagan A. Wright, PhD, MSPH, Gillian Leichtling, BA, Lisa M. Millet, MSH

Erschienen in: Journal of General Internal Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Long-term efficacy of opioids for non-cancer pain is unproven, but risks argue for cautious prescribing. Few data suggest how long or how much opioid can be prescribed for opioid-naïve patients without inadvertently promoting long-term use.

Objective

To examine the association between initial opioid prescribing patterns and likelihood of long-term use among opioid-naïve patients.

Design

Retrospective cohort study; data from Oregon resident prescriptions linked to death certificates and hospital discharges.

Participants

Patients filling opioid prescriptions between October 1, 2012, and September 30, 2013, with no opioid fills for the previous 365 days. Subgroup analyses examined patients under age 45 who did not die in the follow-up year, excluding most cancer or palliative care patients.

Main Measures

Exposure: Numbers of prescription fills and cumulative morphine milligram equivalents (MMEs) dispensed during 30 days following opioid initiation (“initiation month”). Outcome: Proportion of patients with six or more opioid fills during the subsequent year (“long-term users”).

Key Results

There were 536,767 opioid-naïve patients who filled an opioid prescription. Of these, 26,785 (5.0 %) became long-term users. Numbers of fills and cumulative MMEs during the initiation month were associated with long-term use. Among patients under age 45 using short-acting opioids who did not die in the follow-up year, the adjusted odds ratio (OR) for long-term use among those receiving two fills versus one was 2.25 (95 % CI: 2.17, 2.33). Compared to those who received < 120 total MMEs, those who received between 400 and 799 had an OR of 2.96 (95 % CI: 2.81, 3.11). Patients initiating with long-acting opioids had a higher risk of long-term use than those initiating with short-acting drugs.

Conclusions

Early opioid prescribing patterns are associated with long-term use. While patient characteristics are important, clinicians have greater control over initial prescribing. Our findings may help minimize the risk of inadvertently initiating long-term opioid use.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers, United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–92. Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers, United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–92.
3.
Zurück zum Zitat Juurlink DN, Dhalla IA, Nelson LS. Improving opioid prescribing: the New York City recommendations. JAMA. 2013;309:879–80.CrossRefPubMed Juurlink DN, Dhalla IA, Nelson LS. Improving opioid prescribing: the New York City recommendations. JAMA. 2013;309:879–80.CrossRefPubMed
4.
Zurück zum Zitat Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155:325–8.CrossRef Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155:325–8.CrossRef
5.
Zurück zum Zitat Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573–82.CrossRefPubMedPubMedCentral Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573–82.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–76.CrossRefPubMed Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–76.CrossRefPubMed
7.
Zurück zum Zitat Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, Stewart WF. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776–82.CrossRefPubMed Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, Stewart WF. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776–82.CrossRefPubMed
8.
Zurück zum Zitat Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention workshop. Ann Intern Med. 2015;162:276–86.CrossRefPubMed Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention workshop. Ann Intern Med. 2015;162:276–86.CrossRefPubMed
9.
Zurück zum Zitat Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24:469–78.CrossRefPubMed Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24:469–78.CrossRefPubMed
10.
Zurück zum Zitat Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30:557–64.PubMedPubMedCentral Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30:557–64.PubMedPubMedCentral
11.
Zurück zum Zitat Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–21.CrossRefPubMed Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–21.CrossRefPubMed
12.
13.
Zurück zum Zitat Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686–91.PubMed Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686–91.PubMed
15.
Zurück zum Zitat Deyo RA, Irvine JM, Millet LM, Beran T, O’Kane N, Wright DA, McCarty D. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. Health Aff. 2013;32:603–13.CrossRef Deyo RA, Irvine JM, Millet LM, Beran T, O’Kane N, Wright DA, McCarty D. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. Health Aff. 2013;32:603–13.CrossRef
16.
Zurück zum Zitat Deyo RA, Irvine JM, Hallvik SE, Hildebran C, Beran T, Millet LM, Marino M. Leading a horse to water: facilitating registration and use of a prescription drug monitoring program. Clin J Pain. 2015;31:782–7. Deyo RA, Irvine JM, Hallvik SE, Hildebran C, Beran T, Millet LM, Marino M. Leading a horse to water: facilitating registration and use of a prescription drug monitoring program. Clin J Pain. 2015;31:782–7.
17.
Zurück zum Zitat Campbell KM, Deck D, Krupski A. Record linkage software in the public domain: a comparison of Link Plus, The Link King, and a ‘basic’ deterministic algorithm. Health Informatics J. 2008;14:5–15.CrossRefPubMed Campbell KM, Deck D, Krupski A. Record linkage software in the public domain: a comparison of Link Plus, The Link King, and a ‘basic’ deterministic algorithm. Health Informatics J. 2008;14:5–15.CrossRefPubMed
18.
Zurück zum Zitat Beil H, Preisser JS, Rozier RG. Accuracy of record linkage software in merging dental administrative data sets. J Public Health Dent. 2013;73:89–93.CrossRefPubMed Beil H, Preisser JS, Rozier RG. Accuracy of record linkage software in merging dental administrative data sets. J Public Health Dent. 2013;73:89–93.CrossRefPubMed
21.
Zurück zum Zitat O’Kane N, Hallvik SE, Marino M, Van Otterloo J, Hildebran C, Leichtling G, Deyo RA. Preparing a prescription drug monitoring program data set for research purposes. Pharmacoepidemiol Drug Saf. 2016. doi:10.1002/pds.4039.PubMedPubMedCentral O’Kane N, Hallvik SE, Marino M, Van Otterloo J, Hildebran C, Leichtling G, Deyo RA. Preparing a prescription drug monitoring program data set for research purposes. Pharmacoepidemiol Drug Saf. 2016. doi:10.​1002/​pds.​4039.PubMedPubMedCentral
24.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA. 2016;315:1624–45.CrossRefPubMed Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA. 2016;315:1624–45.CrossRefPubMed
25.
Zurück zum Zitat Morden NE, Munson JC, Colla CH, Skinner JS, Bynum JPW, Zhou W, Meara E. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care. 2014;52:852–9.CrossRefPubMedPubMedCentral Morden NE, Munson JC, Colla CH, Skinner JS, Bynum JPW, Zhou W, Meara E. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care. 2014;52:852–9.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Cochran WG. Some methods for strengthening the common chi-squared tests. Biometrics. 1954;10:417–51.CrossRef Cochran WG. Some methods for strengthening the common chi-squared tests. Biometrics. 1954;10:417–51.CrossRef
27.
Zurück zum Zitat Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375–86.CrossRef Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375–86.CrossRef
28.
Zurück zum Zitat Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174:796–801.CrossRefPubMed Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174:796–801.CrossRefPubMed
29.
Zurück zum Zitat Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87–95.CrossRefPubMed Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87–95.CrossRefPubMed
30.
Zurück zum Zitat Hooten WM, St. Sauver JL, McGree ME, Jacobson DJ, Warner DO. Incidence and risk factors for progression from short-term to episodic or long-term opioid prescribing: a population-based study. Mayo Clin Proc. 2015;90:850–6.CrossRefPubMedPubMedCentral Hooten WM, St. Sauver JL, McGree ME, Jacobson DJ, Warner DO. Incidence and risk factors for progression from short-term to episodic or long-term opioid prescribing: a population-based study. Mayo Clin Proc. 2015;90:850–6.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145:287–93.CrossRefPubMedPubMedCentral Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145:287–93.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31:564–70.CrossRefPubMedPubMedCentral Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31:564–70.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Edlund MJ, Martin BC, Devries A, Ming-Yu F, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26:1–8.CrossRefPubMedPubMedCentral Edlund MJ, Martin BC, Devries A, Ming-Yu F, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26:1–8.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Mistry CJ, Bawor M, Desai D, Marsh DC, Samaan Z. Genetics of opioid dependence: a review of the genetic contribution to opioid dependence. Curr Psychiatr Rev. 2014;10:156–67.CrossRef Mistry CJ, Bawor M, Desai D, Marsh DC, Samaan Z. Genetics of opioid dependence: a review of the genetic contribution to opioid dependence. Curr Psychiatr Rev. 2014;10:156–67.CrossRef
36.
Zurück zum Zitat Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H, Farrer LA. Genome-Wide Association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry. 2014;76:66–74.CrossRefPubMed Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H, Farrer LA. Genome-Wide Association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry. 2014;76:66–74.CrossRefPubMed
37.
Zurück zum Zitat Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.CrossRefPubMedPubMedCentral Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38–47.PubMed Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38–47.PubMed
39.
Zurück zum Zitat Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, Gagnon DR. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175:608–15.CrossRefPubMed Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, Gagnon DR. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175:608–15.CrossRefPubMed
40.
Zurück zum Zitat Dowell D, Kunins HV, Farley TA. Opioid analgesics – risky drugs, not risky patients. JAMA. 2013;309:2219–20.CrossRefPubMed Dowell D, Kunins HV, Farley TA. Opioid analgesics – risky drugs, not risky patients. JAMA. 2013;309:2219–20.CrossRefPubMed
Metadaten
Titel
Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study
verfasst von
Richard A. Deyo, MD, MPH
Sara E. Hallvik, MPH
Christi Hildebran, LMSW
Miguel Marino, PhD
Eve Dexter, MS
Jessica M. Irvine, MS
Nicole O’Kane, PharmD
Joshua Van Otterloo, MSPH
Dagan A. Wright, PhD, MSPH
Gillian Leichtling, BA
Lisa M. Millet, MSH
Publikationsdatum
02.08.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 1/2017
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3810-3

Weitere Artikel der Ausgabe 1/2017

Journal of General Internal Medicine 1/2017 Zur Ausgabe

Clinical Practice: Clinical Images

Minocycline-induced Hyperpigmentation

Healing Arts: Materia Medica

Stained

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.